UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended ~~October~~January 31, ~~2024~~2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 000-54851

DEFENSE TECHNOLOGIES INTERNATIONAL CORP.

(Exact name of registrant as specified in its charter)

Delaware		99-0363802
(State of Incorporation)		(I.R.S. Employer Identification Number)

6700 N.North Linder Road, ~~Ste.~~Suite 156-361, Meridian, Idaho 83646

(Address of principal executive offices)

(800) 520-9485

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically ~~and posted on its corporate Web site, if any,~~ every Interactive Data File required to be submitted ~~and posted~~ pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit ~~and post~~ such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~December~~March 2331, ~~2024~~2025, there were 3034,~~947~~147,~~919~~881 shares of the registrant’s common stock, 2,~~562~~535,135 Series A preferred and 1,~~063~~100,~~255~~254 Series B preferred and ~~579~~560 Series D preferred: $0.0001 par value, outstanding.

DEFENSE TECHNOLOGIES INTERNATIONAL CORP.

FORM 10-Q

FOR THE THREE AND ~~SIX~~NINE-MONTH PERIODS ENDED ~~OCTOBER~~ JANUARY 31, ~~2024~~2025 AND ~~2023~~2024

TABLE OF CONTENTS

	PART I — FINANCIAL INFORMATION	~~PART I — FINANCIAL INFORMATION~~	Page	~~Page~~
Item 1.	Financial Statements:	~~Financial Statements:~~	3
		Condensed Consolidated Balance Sheets as of October 31, 2024 (Unaudited) and April 30, 2024 (Audited)			3
	Condensed Consolidated Balance Sheets as of January 31, 2025 (Unaudited) and April 30, 2024 (Audited)		3
		Condensed Consolidated Statements of Operations for the Three and Six Month Periods Ended October 31, 2024 and 2023 (Unaudited)			4
	Condensed Consolidated Statements of Operations for the Three and Nine Month Periods Ended January 31, 2025 and 2024 (Unaudited)		4
		Condensed Consolidated Statements of Stockholders Deficit for the Three and Six Months Ended October 31, 2024 and 2023 (Unaudited)			5
	Condensed Consolidated Statements of Stockholders Deficit for the Three and Nine Months Ended January 31, 2025 and 2024 (Unaudited)		5
		Condensed Consolidated Statements of Cash Flows for the Six Month Periods Ended October 31, 2024 and 2023 (Unaudited)			6
	Condensed Consolidated Statements of Cash Flows for the Nine Month Periods Ended January 31, 2025 and 2024 (Unaudited)		6
	Notes to Condensed Consolidated Financial Statements	~~Notes to Condensed Consolidated Financial Statements~~	7		7
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	~~Management's Discussion and Analysis of Financial Condition and Results of Operations~~	15		15
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	~~Quantitative and Qualitative Disclosures about Market Risk~~	17		17
Item 4.	Controls and Procedures	~~Controls and Procedures~~	17		17
	PART II — OTHER INFORMATION	~~PART II — OTHER INFORMATION~~
Item 1.	Legal Proceedings	~~Legal Proceedings~~	18		18
Item 1A.	Risk Factors	~~Risk Factors~~	18		18
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds.	~~Unregistered Sales of Equity Securities and Use of Proceeds.~~	18		18
Item 3.	Defaults upon Senior Securities	~~Defaults upon Senior Securities~~	18		18
Item 4.	Mine Safety Disclosure	~~Mine Safety Disclosure~~	18		18
Item 5.	Other Information	~~Other Information~~	18		18
Item 6.	Exhibits	~~Exhibits~~	19		19
	Signatures	~~Signatures~~	20		20

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

Defense Technologies International Corp. and Subsidiary
Condensed Consolidated Balance Sheets
	October 31, 2024			April 30, 2024
	January 31, 2025			April 30, 2024
	(Unaudited)			(Audited)
ASSETS
Current assets:
Cash	$	~~228~~2,597		$	171
Inventory		7,599			7,599
Total current assets		710,~~827~~196			7,770
Total assets	$	710,~~827~~196		$	7,770
Current liabilities:
Accounts payable and accrued expense	$	5780,~~349~~028		$	386,003
Accrued licenses agreement payable		-			87,500
Accrued interest and fees payable		~~187~~194,~~963~~421			178,188
Convertible notes payable, net of discount		~~279~~185,~~085~~762			279,085
Derivative liabilities		2924,~~754~~121			37,211
Payables – related parties		~~526~~557,~~958~~407			1,191,708
Customer deposits		40,375			40,375
Notes payable		70,042			20,042
Stock payable		24.000			-
Note payable- related party		150,680			150,020
Notes payable		247,188			20,042
Total current liabilities		1,342,206			2,370,132
Note payable- related party		135,717			150,020
Total liabilities		1,342,206			2,370,132
Total current liabilities		1,489,019			2,370,132
Total liabilities		1,489,019			2,370,132
Commitments and Contingencies		-			-
Stockholders’ deficit:
Preferred stock, $0.0001 par value; 20,000,000 shares authorized, Series A – 2,535,135 and 2,535,135 shares issued and outstanding, respectively		253			253
Series B –1,063,255 and 1,860,636 shares issued and outstanding, respectively		106			186
Series B –1,100,254 and 1,860,636 shares issued and outstanding, respectively		110			186
Series D – 579 and 600 shares issued and outstanding, respectively		-			-
Series D – 560 and 600 shares issued and outstanding, respectively		-			-
Common stock, $0.0001 par value; 600,000,000 shares authorized, 30,947,919 and 9,729,878 shares issued and outstanding, respectively		3,096			974
Common stock, $0.0001 par value; 600,000,000 shares authorized, 34,147,881 and 9,729,878 shares issued and outstanding, respectively		3,416			974
Additional paid-in capital		16,~~181~~316,~~447~~813			15,067,580
Accumulated deficit		(17,~~193~~468,~~733~~501	)		(17,116,309	)
Total		(1,~~008~~147,~~831~~909	)		(2,047,316	)
Non-controlling interest		(~~325~~330,~~548~~914	)		(315,046	)
Total stockholders’ deficit		(1,~~334~~478,~~379~~823	)		(2,362,362	)
Total liabilities and stockholders’ deficit	$	710,~~827~~196		$	7,770

See notes to condensed consolidated financial statements

Table of Contents

Defense Technologies International Corp. and Subsidiary Condensed Consolidated Statements of Operations As of ~~October~~January 31, (Unaudited)

	Three Months						~~Six~~Nine Months
	2024			2023			2024			2023
	2025			2024			2025			2024
Revenue	$	-		$	~~49,012~~-		$	-		$	49,012
Cost of goods sold		-			~~(24,395~~-	)		-			(24,~~395~~405	)
Gross margin		-			~~24,617~~-			-			24,~~617~~607
Expenses:
Consulting	$	~~219~~93,~~292~~200			~~112~~110,~~637~~000			~~336~~429,~~792~~992			~~232~~342,637
Development		-			-			-			~~332~~322
General and administrative		~~146~~223,~~773~~603			5531,~~573~~270			~~192~~421,~~790~~758			75107,~~989~~250
Total expenses		~~366~~316,~~065~~803			~~168~~141,~~210~~270			~~529~~851,~~582~~750			~~308~~450,~~948~~209
Loss from operations		(~~366~~316,~~065~~803	)		(~~143~~141,~~593~~270	)		(~~529~~851,~~582~~750	)		(~~284~~425,~~331~~602	)
Other income (expense):
Gain in debt settlement		~~723~~50,~~065~~166			-25,000			~~723~~773,~~065~~231			-25,000
Gain (loss )on accounts payable		45,000			-			(250,000	)		-
Gain (loss) on accounts payable		-			-			(250,000	)		-
Interest and other income (expense)		(76,~~096~~408	)		(76,~~189~~771	)		(1430,~~154~~562	)		(1421,~~559~~330	)
Loan origination fee		-(15,000	)		-			(540,~~000~~500	)		-
Loss on notes		-			-			(5,000	)		-
Gain (loss) on derivative liability		5,633			226			13,090			(16,528	)
Gain (loss) on derivative liability		(709	)		(28,980	)		7,457			(16,756	)
Total other income (expense)		49,391			18,455			505,759			(12,858	)
Total other income (expense)		760,260			(36,169	)		456,368			(31,315	)
Income (loss) before income taxes		(267,412	)		(122,815	)		(345,991	)		(438,460	)
Income (loss) before income taxes		394,195			(179,762	)		(73,214	)		(315,646	)
Provision for income taxes		-			-			-			-
Provision for income taxes					-			-			-
Net income (loss) before non-controlling interest		(267,412	)		(122,815	)		(345,991	)		(438,389	)
Net income (loss) before non-controlling interest		394,195			(179,762	)		(73,214	)		(315,646	)
Non- controlling interest in net loss of the consolidated subsidiary		5,366			1,212			(15,867	)		10,071
Non- controlling interest in net loss of the consolidated subsidiary		4,332			645			10,502			8,410
Net income (loss) attributed to the Company	$	(272,768	)	$	(121,603	)	$	(330,124	)	$	(428,389	)
Net income (loss) attributed to the Company	$	398,527		$	(179,117	)	$	(62,712	)	$	(307,236	)
Net income (loss) per common share: Basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.01	)	$	(0.11	)
Net income (loss) per common share: Basic	$	0.01		$	(0.06	)	$	(0.00	)	$	(0.11	)
Net income (loss) per common share; Diluted	$	0.01		$	(0.06	)	$	(0.00	)	$	(0.11	)
Weighted average common shares outstanding:
Basic		30,947,919			3,214,074			29,243,883			2,709,309
Basic and diluted		32,207,256			8,942,736			27,175,776			3,424,670
Weighted average common shares outstanding: Diluted		66,931,819			3,214,074			29,243,883			2,709,309

See notes to condensed consolidated financial statements

Table of Contents

Defense Technologies International Corp. and Subsidiary

Condensed Consolidated Statements of Stockholders’ Deficit

For the Three and ~~Six~~ Nine Months Ended ~~October~~January 31, ~~2024~~2025 and ~~2023~~2024

(Unaudited)

	Preferred stock						Common Stock				Additional Paid-In			Accumulated			Non- Controlling			Total Stockholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Interest			Deficit
Balance at April 30, 2023		4,839,616			483			1,803,042		181		14,905,851			(16,527,130	)		(299,035	)		(1,919,650	)
Common stock issued for debt conversion		-			-			569,681		57		14,629			-			-			14,686
Common stock issued for cash		-			-			200,000		20		9,980			-			-			10,000
Common stock issued for preferred B share conversion		(7,208	)		-			72,081		7		(15	)		-			-			(8	)
Common stock issued for D shares conversion		(3	)					115,955		12		-			-			-			12
Derivative at conversion		-			-			-		-		19,354			-			-			19,354
Dividends on Series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(127,474	)		(9,055	)		(136,529	)
Balance at July 31, 2023		4,832,405			483			2,760,759		277		14,957,155			(16,661,960	)		(308,090	)		(2,012,135	)
Common stock issued for debt conversion		-			-			543,898		54		8,275			-			-			8,329
Common stock issued for preferred B shares conversion		(41,750	)		(4	)		465,000		47		(45	)		-			-			-
Series B shares issued for service		85,000			7			-		-		15,133			-			-			15,140
Derivative at conversion		-			-			-		-		21,819			-			-			21,819
Dividend on series D shares		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(179,762	)		645			(179,117	)
Balance at October 31, 2023		4,875,655			486			3,769,657		378		15,009,693			(16,849,078	)		(307,445	)		(2,145,964	)
Common stock issued for debt conversion		-			-			149,038		15		2,965			-			-			2,980
Common stock issued for B shares conversion		(39,027	)		(4	)		390,270		39		6			-			-			39
Common stock issued for Series A conversion		(390,234	)		(39	)		3,902,340		390		(390	)		-			-			(39	)
Common stock issued for debt payment		-			-			685,825		69		34,222			-			-			34,291
Common stock issued for D shares conversion		-			-			179,908		18		(18	)		-			-			-
Dividend on series D shares		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(121,603	)		(1,212	)		(122,815	)
Balance at January 31, 2024		4,441,641			441			9,027,038		909		15,055,854			(16,978,037	)		(308,657	)		(2,231,508	)
Balance at April 30, 2024		4,396,363			439			9,729,878		974		15,067,580			(17,116,309	)		(315,046	)		(2,362,362	)
Common stock issued for B preferred conversion		(1,068,686	)		(107	)		10,686,860		1,069		(962	)		-			-			-
Common stock issued for D preferred conversion		(7	)		-			431,181		43		(43	)					-			-
Common stock issued for accrued expense – RP		-			-			10,000,000		1,000		694,000			-			-			695,000
Common stock issued for services		-			-			100,000		10		9,990			-			-			10,000
Dividends on series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(461,239	)		(6,170	)		(467,409	)
Balance at July 31, 2024		3,327,664			332			30,947,919		3,096		15,777,921			(17,584,904	)		(321,216	)		(2,124,771	)
Series B shares issued for accrued expenses		191,314			19			-		-		789,313			-			-			789,332
Series B shares issued for accrued expenses-RP		79,991			8			-		-		329,922			-			-			329,930
Settlement on debt		-			-			-		-		(723,065	)		-			-			(723,065	)
Dividends on series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			398,527			(4,332	)		394,195
Balance at October 31, 2024		3,598,969			359			30,947,919		3,096		16,181,447			(17,193,733	)		(325,548	)		(1,334,379	)
B series issued for accrued expenses		22,000			3			-		-		54,496			-			-			54,499
B series issued for accrued expense- RP		15,000			1			-		-		37,500			-			-			37,501
Common stock issued for service		-			-			750,000		75		44,925			-			-			45,000
Common stock issued for convertible notes		-			-			1,250,000		125		62,375			-			-			62,500
Common stock issued for Series D shares conversion								1,199,962		120		(120	)		-			-			-
Debt settlement												(50,166	)								(50,166	)
Stock based compensation												(21,000	)								(21,000	)
Dividend on series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss															(267,412	)		(5,366	)		(272,778	)
Balance at January 31, 2025		3,635,969		$	363			34,147,881	$	3,416	$	16,316,813		$	(17,468,501	)	$	(330,914	)	$	(1,478,823	)

	Preferred Stock						Common Stock				Additional Paid-In			Accumulated			Non-Controlling			TotalStockholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Interest			Deficit
Balance at April 30, 2023		4,839,616		$	483			1,803,042	$	181	$	14,905,851		$	(16,527,130	)	$	(299,035	)	$	(1,919,650	)
Common stock issued for debt conversion		-			-			569,681		57		14,629			-			-			14,686
Common stock issued for cash		-			-			200,000		20		9,980			-			-			10,000
Common stock issued for preferred B share conversion		(7,208	)		-			72,081		7		(15	)		-			-			(8	)
Common stock issued for D shares conversion		(3	)					115,955		12		-			-			-			12
Derivative at conversion		-			-			-		-		19,354			-			-			19,354
Dividends on Series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(127,474	)		(9,055	)		(136,529	)
Balance at July 31, 2023		4,832,405			483			2,760,759		277		14,957,155			(16,661,960	)		(308,090	)		(2,012,135	)
Common stock issued for debt conversion		-			-			543,898		54		8,275			-			-			8,329
Common stock issued for preferred B shares conversion		(41,750	)		(4	)		465,000		47		(45	)		-			-			-
Series B shares issued for service		85,000			7			-		-		15,133			-			-			15,140
Derivative at conversion		-			-			-		-		21,819			-			-			21,819
Dividend on series D shares		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(179,762	)		645			(179,117	)
Balance at October 31, 2023		4,875,655			486			3,769,657		378		15,009,693			(16,849,078	)		(307,445	)		(2,145,964	)
Balance at April 30, 2024		4,396,363			439			9,729,878		974		15,067,580			(17,116,309	)		(315,046	)		(2,362,362	)
Common stock issued for B preferred conversion		(1,068,686	)		(107	)		10,686,860		1,069		(962	)		-			-			-
Common stock issued for D preferred conversion		(7	)		-			431,181		43		(43	)					-			-
Common stock issued for accrued expense – RP		-			-			10,000,000		1,000		694,000			-			-			695,000
Common stock issued for services		-			-			100,000		10		9,990			-			-			10,000
Dividends on series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(461,239	)		(6,170	)		(467,409	)
Balance at July 31, 2024		3,327,664			332			30,947,919		3,096		15,777,921			(17,584,904	)		(321,216	)		(2,124,771	)
Series B shares issued for accrued expenses		191,314			19			-		-		789,313			-			-			789,332
Series B shares issued for accrued expenses-RP		79,991			8			-		-		329,922			-			-			329,930
Settlement on debt		-			-			-		-		(723,065	)		-			-			(723,065	)
Dividends on series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			398,527			(4,332	)		394,195
Balance at October 31, 2024		3,598,969		$	359			30,947,919	$	3,096	$	16,181,447		$	(17,193,733	)	$	(325,548	)	$	(1,334,379	)

See notes to condensed consolidated financial statements

Table of Contents

Defense Technologies International Corp and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Six Months Ended October 31,
	Nine Months Ended January 31,
	2024			2023
	2025			2024
Cash flows from operating activities:
Net loss	$	(73345,~~214~~991	)	$	(~~315~~438,~~646~~460	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock issued for service		1058,000			-
Preferred shares issued for service		-			15,~~140~~138
(Gain) loss on derivative liability		(713,~~457~~090	)		16,~~756~~528
Loss on notes		10,000			-
Debt discount		9,677			-
Gain on debt extinguishment		(428,065	)		-
Loan origination fees		40,500			-
Gain on debt extinguishment		(773,231	)		-
Change in operating assets and liabilities:
(Increase) decrease in accounts receivable		-			(31,224	)
(Increase) decrease in inventory		-			26,913
(Increase) decrease in inventory		-			26,903
Increase (decrease) in accounts payable and accrued expenses		506,860			154,209
Increase (decrease) in accounts payable and accrued expenses		382,953			109,070
Customer deposits		-			10,000
Increase in payables – related parties		65390,~~180~~629			~~145~~210,~~099~~334
Net cash provided by (used in) operating activities		(40167,~~603~~146	)		(235,~~902~~338	)
Cash flows from financing activities
Proceeds from notes payable- related party		933			1,400
Repayment of notes payable- related party		6,975			5,338
Proceeds from notes payable		40178,000			-
Repayment of notes payable		(~~273~~15,403	)		(530,500	)
Proceeds from convertible notes		-			20,000
Proceeds from common stock for cash		-			10,000
Net cash provided by financing activities		40169,~~660~~572			254,~~900~~838
Net increase (decrease) in cash		572,426			~~1,998~~(500	)
Cash at beginning of period		171			804
Cash at end of period	$	~~228~~2,597		$	~~2,802~~304
Supplement Disclosures
Interest Paid		-			-
Income tax Paid		-			-
Noncash financing and investing activities
Retirement of derivative at debt conversion	$	-		$	41,173
Interest accrued on preferred shares	$	1422,~~712~~068		$	14,712
Common stock issued for convertible debt	$	-65,000		$	2125,~~809~~996
Common stock issued for conversion of Series A preferred	$	400,000		$	-(39	)
Series B preferred issued for notes payable and accrued interest	$	-		$	-
Common stock issued for accrued expenses- related party	$	704,000		$	-
Series B preferred issued for accrued expense	$	~~789~~904,~~332~~409		$	-34,292
Series B preferred issued for accrued expense – relate parties	$	~~331~~337,992		$	-
Common stock issued for conversion of preferred shares	$	-		$	(8	)

See notes to condensed consolidated financial statements

Table of Contents

Defense Technologies International Corp. and Subsidiary

Notes to Condensed Consolidated Financial Statements

As of ~~October~~January 31, ~~2024~~2025

(Unaudited)

NOTE – 1: BASIS OF PRESENTATION AND ORGANIZATION

Defense Technologies International Corp. (the "Company ") was incorporated in the State of Delaware on May 27, 1998. Effective June 15, 2016, the Company changed its name to Defense Technologies International Corp. from Canyon Gold Corp. to more fully represent the Company's expansion goals into the advanced technology sector.

On October 19, 2016, the Company entered into a Definitive Agreement with Controlled Capture Systems, LLC (“CCS”), representing the inventor of the technology and assets previously acquired by DTC, that included a new exclusive Patent License Agreement and Independent Contractor agreement. Under the license agreement with CCS, the Company acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products and improvements. The Company agreed to pay CCS an initial licensing fee of $25,000 and to pay ongoing royalties as defined in the Definitive Agreement. On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows (1) Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter (2) All payment will be in US dollars or stock of the Company and its subsidiary. The value of the stock will be a discount to the market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive (3) Invoices for parts and materials will be billed separate of the license fees noted above.

Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and security protection products previously acquired by the Company. The Company currently owns 76.28% of PSSI with 23.72% acquired by several individuals and entities. The Company’s unique technology works precisely to specifications as required by our technology and as confirmed in the market. All sales and marketing activities will be executed through PSSI.

On June 28, 2022 the Company’s common shares were reversed with each shareholder receiving one share of common stock for each 500 shares held before the reverse split. The number of shares throughout the disclosure have been retrospectively adjusted to represent the number of shares after the reverse split.

Basis of Presentation

These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The Company’s fiscal year end is April 30.

The interim condensed consolidated financial statements have been prepared without audit in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q. They do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended April 30, 2024 included in its Annual Report on Form 10-K filed with the SEC.

The interim condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s consolidated financial position as of ~~October~~January 31, ~~2024~~2025, the consolidated results of its operations and its consolidated cash flows for the ~~six~~nine months ended ~~October~~January 31, ~~2024~~2025 and ~~2023~~2024. The results of operations for any interim period are not necessarily indicative of the results expected for the full fiscal year.

Table of Contents

Consolidation and Non-Controlling Interest

These consolidated financial statements include the accounts of the Company, and its majority-owned subsidiary, PSSI, from its formation on January 12, 2017 to date. All inter-company transactions and balances have been eliminated.

Inventory

Inventories are stated at the lower of cost using the first-in, first-out (FIFO) cost method of accounting. Inventories as of ~~October~~January 31, ~~2024~~2025 consist of parts used in assembly of the units being sold plus work in progress and finished goods. As of ~~October~~January 31, ~~2024~~2025 and April 30, 2024 the value of the inventory was $7,599.

Equipment

Equipment is carried at the cost of acquisition and depreciated over the estimated useful lives of the assets. Costs associated with repair and maintenance is expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of our property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Impairment of Long-Lived Assets

We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.

Net Income (Loss) per Common Share

Basic net income or loss per common share is calculated by dividing the Company’s net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per common share is calculated by dividing the Company’s net income or loss by sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents then outstanding. Potential dilutive common share equivalents consist of shares issuable upon exercise of outstanding stock options and warrants, using the treasury stock method and the average market price per share during the period, and conversion of convertible debt, using the if converted method. As of ~~October~~January 31, ~~2024~~2025, the Company had potential shares issuable under convertible preferred shares and convertible debt for a total of 3536,~~983~~353,900.

Table of Contents

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU) No 2020-06 Debt with Conversion and Other Options (Subtopic 470-20) and Derivative and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contract’s in an Entity’s own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods has been amended for small businesses to beginning after December 15, 2023 as early adoption was permitted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company evaluated there is no impact this new guidance will have on its financial statements.

8In ~~Table~~November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07 Segment Reporting The change in this announcement requires more detailed profit and loss reporting by business segments used by the Company to determine the allocation of ~~Contents~~assets. ASU 2016-07 is effective for annual periods beginning after December 15, 2023 and interim periods within the fiscal years beginning December 15, 2024. The Company is evaluating the adoption of the standard but believe it will not have a material impact on the Company’s consolidated financial statements.

NOTE – 2: GOING CONCERN

These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applicable to a going concern. Through ~~October~~January 31, ~~2024~~2025, the Company had no revenues, has accumulated deficit of $17,~~193~~468,~~733~~501 and a working capital deficit of $1,~~334~~478,~~379~~823 and expects to incur further losses in the development of its business. The Company has not yet established an ongoing source of revenue sufficient to cover operating costs, which raises substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.

Management plans to continue to provide for the Company's capital needs during the year ending April 30, 2025 by issuing debt and equity securities and by the continued support of its related parties. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

NOTE – 3: INVESTMENTS

Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company for 17,500 shares of PSSI valued at $378,600 for 76.28% of PSSI. The balance of PSSI was acquired by four individuals and entities. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI. The investment was impaired as of April 30, 2019.

NOTE – 4: RELATED PARTY TRANSACTIONS

Management and administrative services are currently compensated as per a Service Agreement between the Company and its Chief Executive Officer and Director executed on April 25, 2016 and a Service Agreement with the subsidiary PSSI executed on January 12, 2017, a Service Agreement between the Company and a Director executed on May 20, 2016, and an Administration Agreement with a related party executed on March 15, 2011 and renewed on May 1, 2017 and renewed in August 21, 2020 plus the assumption of a Service Agreement with the subsidiary PSSI assumed on January 12, 2017 and renewed on August 21, 2020, whereby the fee is based on services provided and invoiced by the related parties on a monthly basis and the fees are paid in cash when possible or with common stock. The Company also, from time to time, has some of its expenses paid by related parties with the intent to repay. These types of transactions, when incurred, result in payables to related parties in the Company’s consolidated financial statements as a necessary part of funding the Company’s operations.

Table of Contents

On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum. As of ~~October~~January 31, ~~2024~~2025, the outstanding balance on the loan agreement was $~~150~~108,~~080~~632 plus accrued interest.

During the ~~six~~nine months ~~ending~~period ~~October~~ended January 31, ~~2023~~2024, the Company issued 85,000 series B preferred shares to a related party with a value of $15,140.

During the ~~six~~nine months ~~ending~~period ~~October~~ended January 31, 2024, the Company issued 103,~~686~~902,~~860~~340 shares of common stock for the conversion of 1390,~~068,686~~234 of ~~Series~~series BA preferred shares.to a related party.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 10,000,000 shares of common stock with an aggregate value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 7994,991 shares of series B preferred with a value of $~~329~~367,~~930~~431 to 2 related parties for accrued liabilities. ~~The transaction resulted in a gain on debt settlement which was recorded as paid in capital.~~

As of ~~October~~January 31, ~~2024~~2025 and April 30, 2024, the Company had payable balances due to related parties totaling $~~526~~557,~~958~~308 and $1,191,708, respectively.

NOTE – 5: NOTES PAYABLE

On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $25,000. The funds were designated for use in a marketing agreement with the Edward Fitzgerald Group for raising funds for PSSI. The note was to be repaid from investment funds generated by the Fitzgerald group plus 15% of the funds generated are paid to the investor.

On July 18, 2018, the Company entered into a promissory note of $114,226.26 with interest rate of 8% per annum with Haynie & Company the Company’s former auditors. Under the terms of the agreement commencing August 15, 2018 the Company is to pay Haynie $5,000 per month. In addition, the Company shall pay the noteholder 20% of any funding event of private or public equity. On July 11, 2022, the Company negotiated a settlement of $37,500 with an initial payment of $30,000 and the balance due of $7,500 thirty days after the initial payment. As of ~~October~~January 31, ~~2024~~2025 ~~$7,500~~the note had not been paid leaving the balance due on the note of $20,042.

On July 1110, 2024 the Company issued a promissory note for $50,000, The note matures in one year from issuance and bears interest at 10% per annum. The note has an initial discount of $10,000 and is not convertible.

AsOn ofDecember ~~October 31~~13, 2024 ~~and~~the ~~April~~Company ~~30,~~issued ~~2024~~a ~~the~~promissory ~~outstanding~~note ~~balances~~to ofMayday ~~notes~~Management ~~payable~~Inc, ~~was~~for $~~220~~12,~~772~~500 plus interest and cost of $~~170~~845.83. The note is due on February 10,~~062,~~ ~~respectively~~2025.

~~NOTE~~On –December ~~6: CONVERTIBLE~~26, ~~DEBT~~2024 the Company issued a promissory note for $50,000. The note matures July 11, 2025. The note has an initial discount of $10,000 and is not convertible.

On March 10, 2016, the Company entered into a convertible promissory note for $17,000 with ACM Services GmbH, which bears interest at an annual rate of 6% and is convertible into shares of the Company’s common stock at $0.05 per share. The Company recorded a debt discount and a beneficial conversion feature of $17,000 at the inception of the note. As of October 31, 2024 the balance of the notes was $7,000 plus interest.

On August 3, 2016, the Company entered into a convertible promissory note with an institutional investor for $25,000, which bears interest at an annual rate of 12% and matures on February 4, 2017. The note holder has the right, after a period of 180 days of the note, to convert the note and accrued interest into shares of the common stock of the Company at a discounted price per share equal to 50% to 65% of the market price of the Company’s common stock, depending upon the stock’s liquidity as determined by the note holder’s broker. On March 20, 2017, the lender converted $12,500 principal into 1,000,000 shares of the Company’s common stock. As of October 31, 2024 the note has a balance of $12,500 plus interest and is currently in default.

Table of Contents

On ~~October~~December 413, ~~2018,~~ 2024 the Company ~~entered into an agreement with RAB Investments AG to consolidate all RAB outstanding notes~~ issued bya ~~the~~promissory ~~Company~~note ~~prior~~for ~~to October 31~~$12, ~~2018~~000. ~~Under~~The ~~the~~note ~~terms~~matures ofJuly ~~the~~11, ~~agreement the Company agreed to accept a six percent interest to be calculated on all the notes since their inception~~2025. The ~~agreement~~note ~~resulted~~has inan ainitial ~~new~~discount ~~note~~of ~~for~~ $~~330~~2,~~626~~000 ~~which included the additional interest~~ and ~~retired~~is ~~the~~not ~~original notes~~convertible. ~~As of October 31, 2024, the outstanding balance was $259,585 plus accrued interest.~~

On ~~March~~January 107, ~~2022,~~ 2025 the Company issued ~~657,895 shares of series A preferred with~~ a ~~value~~promissory ofnote $for 25$50,000. ~~for~~The ~~payment against the convertible~~ note. Asmatures ofJuly ~~October 31~~11, ~~2024,~~2025. ~~and~~The ~~April~~note ~~30,~~has ~~2024,~~an ~~the~~initial ~~outstanding~~discount ~~balance~~ of ~~the note were~~ $~~259~~10,~~585~~000 ~~plus~~and ~~interest.~~is not convertible

~~During~~On January 21, 2025 the ~~six~~Company ~~months~~issued ~~ended~~a ~~October~~promissory 31note for $43,500. ~~2023~~The ~~the~~note ~~Company~~matures ~~issued~~July 111,~~113,579~~ ~~shares~~2025. ofThe ~~common~~note ~~stock~~has ~~with~~an ainitial ~~value~~discount of $238,~~016~~500 ~~for~~and ~~the~~is ~~conversion~~not ~~of debt.~~convertible

~~During~~As ~~the~~of ~~six~~January ~~months~~31, 2025 ~~ending~~and ~~October~~April 3130, 2024 the ~~Company~~outstanding ~~issued~~balances ~~10,000,000~~of ~~with~~notes apayable was ~~value of~~ $~~695~~382,~~000~~905 ~~for~~and ~~the payment of related party debt. As part of the conversion the Company recognized a loss on notes of~~ $~~295~~170,~~000~~062, respectively.

AsNOTE of6: ~~October~~CONVERTIBLE ~~31, 2024, and April 30, 2024, the convertible debt outstanding, net of discount, was $279,085.~~DEBT

~~NOTE~~On –March ~~7: FAIR~~10, ~~VALUE~~2016, ~~MEASUREMENTS~~the ~~AND~~Company ~~DERIVATIVE~~entered ~~LIABILITIES~~into a convertible promissory note for $17,000 with ACM Services GmbH, which bears interest at an annual rate of 6% and is convertible into shares of the Company’s common stock at $0.05 per share. The Company recorded a debt discount and a beneficial conversion feature of $17,000 at the inception of the note. As of January 31, 2025 the balance of the notes was $7,000 plus interest.

On August 3, 2016, the Company entered into a convertible promissory note with an institutional investor for $25,000, which bears interest at an annual rate of 12% and matures on February 4, 2017. The note holder has the right, after a period of 180 days of the note, to convert the note and accrued interest into shares of the common stock of the Company at a discounted price per share equal to 50% to 65% of the market price of the Company’s common stock, depending upon the stock’s liquidity as determined by the note holder’s broker. On March 20, 2017, the lender converted $12,500 principal into 1,000,000 shares of the Company’s common stock. As of January 31, 2025 the note has a balance of $12,500 plus interest and is currently in default.

On October 4, 2018, the Company entered into an agreement with RAB Investments AG to consolidate all RAB outstanding notes issued by the Company prior to October 31, 2018. Under the terms of the agreement the Company agreed to accept a six percent interest to be calculated on all the notes since their inception. The agreement resulted in a new note for $330,626 which included the additional interest and retired the original notes.

On March 10, 2022, the Company issued 657,895 shares of series A preferred with a value of $ 25,000 for payment against the convertible note. During the nine months ended January 31, 2024 the Company issued 1,262,617 shares of common stock with a value of $25,996 for the conversion of debt. During the nine month period ended January 31, 2025 the Company issued 1,250,000 shares of common stock with a value of $62,500 for the conversion of debt. As of January 31, 2025 the note had a balance of $197,085 plus interest.

During the nine months ending January 31, 2025 the Company issued 10,000,000 with a value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000.

As of January 31, 2025, and April 30, 2024, the convertible debt outstanding, net of discount, was $185,762 and $279,085, respectively.

NOTE 7: FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES

As defined in (Financial Accounting Standards Board ASC 820), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy are as follows:

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Table of Contents

AsThe ofthree ~~October~~levels ~~31,~~of ~~2024,~~ the ~~Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their~~ fair ~~values~~value ~~due~~hierarchy toare ~~the~~as ~~nature or duration of these instruments.~~ follows:

The following table represents the change in the fair value of the derivative liabilities during the six months ended October 31, 2024:

Level 1 –		Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

Level 2 –		Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

Level 3 –		Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

	Level 1		Level 2		Level 3
Balance at April 30, 2024	$	-	$	-	$	37,211
Change in fair value of derivative liability		-		-		(7,457	)
Balance at October 31, 2024	$	-	$	-	$	29,754

As of January 31, 2025, the Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their fair values due to the nature or duration of these instruments.

The ~~estimated~~following ~~fair~~table ~~value~~represents of the ~~derivative~~change ~~liabilities~~in atthe ~~October~~fair ~~31,~~value ~~2024~~of ~~was~~the ~~calculated~~derivative ~~using~~liabilities during the ~~Binomial~~nine ~~Lattice~~months ~~pricing~~ended ~~model~~January ~~with~~31, ~~the following assumptions~~2025:

Risk-free interest rate		5.00	%
	Level 1			Level 2		Level 3
Expected life in years		0.10
Balance at April 30, 2024	$	-		$	-	$	37,211
Dividend yield		0	%
Change in fair value of derivative liability		-			-		(13,090	)
Expected volatility		251.00	%
Balance at January 31, 2025	$	-		$	-	$	24,121

~~NOTE~~The –estimated 8:fair ~~EQUITY~~value of the derivative liabilities at January 31, 2025 was calculated using the Binomial Lattice pricing model with the following assumptions:

Risk-free interest rate	4.00	%
Expected life in years	0.10
Dividend yield	0	%
Expected volatility	213.00	%

NOTE 8: EQUITY

Common Stock

On April 26, 2022, the Company filed an amendment to the Articles of Incorporation increasing the authorized shares of common stock to 600,000,000 with a par value of $0.0001 and the total number of preferred shares at 20,000,000, par value $0.0001.

During the six months ended October 31, 2023, the Company issued 200,000 shares of common stock with a value of $10,000 for cash.

During the six months ending October 31, 2023, the Company issued 537,081 shares of common stock for the conversion of 53,708 shares of preferred stock.

During the six months ended October 31, 2023, the Company issued 1,113,579 shares of common stock with a value of $23,016 for the conversion of debt.

During the six months ending October 31, 2024 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares.

During the six months ending October 31, 2024 the Company issued 100,000 shares of common stock with a value of $10,000 for the payment of consulting fees.

During the six months ending October 31, 2024 the Company issued 431,181 shares of common stock for the conversion of 7 shares of series D preferred shares.

During the six months ending October 31, 2024 the Company issued 10,000,000 shares with an aggregate value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000.

Table of Contents

During the nine months period ended January 31, 2024, the Company issued 200,000 shares of common stock with a value of $10,000 for cash.

During the nine months period ended January 31, 2024, the Company issued 5,125,554 shares of common stock for the conversion of 482,972 shares of preferred stock.

During the nine months period ended January 31, 2024, the Company issued 1,262,617 shares of common stock with a value of $25,996 for the conversion of debt.

During the nine months ending January 31, 2025 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares.

During the nine months ending January 31, 2025 the Company issued 850,000 shares of common stock with a value of $55,000 for the payment of consulting fees.

During the nine months ending January 31, 2025 the Company issued 1,631,143 shares of common stock for the conversion of 26 shares of series D preferred shares.

During the nine months ending January 31, 2025 the Company issued 10,000,000 shares with an aggregate value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000.

During the nine months ending January 31, 2025 the Company issued 1,250,000 shares of common stock with a value of $62,500 for the payment of notes payable.

Preferred Stock

The Company has 20,000,000 shares of $0.0001 par value preferred stock authorized and has designated a Series A preferred stock, a Series B preferred stock, a series C preferred stock and a series D preferred stock. The Company has authorized 5,000,000 series A and B shares each plus 1,500,000 each of series C and D preferred shares Each share of the Series A preferred stock is convertible into ten common shares and carries voting rights on the basis of 100 votes per share. Each share of the Series B preferred stock is convertible into ten common shares and carries no voting rights. Each of the Series C preferred shares are non-voting and are convertible to common stock as a “Blank Check” designation with terms and conditions as set by the board of directors. Each of the series D preferred shares are non-voting and may be converted into common shares as a Blank Check” designation with the terms and conditions as set forth by the board of directors

During the ~~six~~nine months ~~ending~~period ~~October~~ended January 31, ~~2023~~2024, the Company issued ~~537~~5,~~081~~125,554 shares of common stock for the conversion of 53482,~~708~~972 shares of preferred stock.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued ~~191~~213,314 shares of series B preferred shares to settle $~~789~~843,~~332~~831 for accrued payables. The result of this issuance was a gain on debt of approximately $~~723~~773,~~065~~231.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 7994,991 shares of series B ~~for~~preferred ~~settling~~with ~~$329,930~~a value of ~~accrued~~ ~~payables~~$367,431 ~~due~~ to 2 related parties for accrued liabilities.

As13 ofTable ~~October 31, 2024 the Company has 3,598,969 shares~~ of preferred stock consisting of; 2,535,135 Series A shares, 1,063,255 Series B shares and 579 Series D preferred share issued and outstanding. The conversion price for the 579 series D shares issued is $0.50 or 80% of the lowest trading price 20 days prior to conversion,Contents

~~NOTE~~As –of ~~9: COMMITMENTS~~January ~~AND~~31, ~~CONTINGENCIES~~2025 the Company has 3,635,949 shares of preferred stock consisting of; 2,535,135 Series A shares, 1,100,254 Series B shares and 560 Series D preferred shares issued and outstanding. The conversion price for the 560 series D shares issued is $0.50 or 80% of the lowest trading price 20 days prior to conversion,

~~The~~NOTE ~~Company~~9: ~~has~~COMMITMENTS ~~the~~AND ~~following material commitments as of October 31, 2024:~~CONTINGENCIES

The Company has the following material commitments as of January 31, 2025:

Administration Agreement with EMAC Handel’s AG, renewed effective May 1, 2017 for a period of three years and amended May 1, 2021. Monthly fee for administration services of $7,500, office rent of $250 and office supplies of $125. Extraordinary expenses are invoiced by EMAC on a quarterly basis. The fee may be paid in cash and or with common stock.

Service Agreement signed April 25, 2016 with Merrill W. Moses, President, Director and CEO, for services of $7,500 per month beginning May 2016 and the issuance of 233 restricted common shares of the Company. The fees may be paid in cash and or with common stock.

Administration and Management Agreement of PSSI signed January 12, 2017 with EMAC Handel Investments AG, for general fees of $7,500 per month, office rent of $250 and telephone of $125 beginning January 2017 and amended May 1, 2021, the issuance of 2,000 common shares of PSSI and a 12% royalty calculated on defines sales revenues payable within 10 days after the monthly sales.

Service Agreement of PSSI signed January 12, 2017 with Merrill W. Moses, President, Director and CEO, for services of $2,500 per month beginning February 2017 and the issuance of 333 common shares of PSSI.

Business Development and Consulting Agreement of PSSI signed January 15, 2017 with WSMG Advisors, Inc., for finder’s fees of 10% of funding raised for PSSI and the issuance of 1,000 common shares of PSSI.

13 Table of Contents

On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows.

· Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter. · All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive. · Invoices for parts and materials will be billed ~~separate~~separately of the license fees noted above.

NOTE – 10: SUBSEQUENT EVENTS

~~The~~On ~~Company~~February ~~has~~12, ~~evaluated~~2025 ~~subsequent~~the ~~events~~Company issued toa ~~determine~~note ~~events~~for ~~occurring after October 31~~$105,000, ~~2024~~with ~~through~~an ~~the~~original ~~filing~~discount of ~~this~~$15,000 ~~report~~to ~~that~~Ionic ~~would~~Ventures ~~have~~Inc. aThe ~~material~~note ~~impact~~is due on ~~the~~July ~~Company’s~~11, ~~financial results or require disclosure other than those noted above~~2025.

The Company has evaluated subsequent events to determine events occurring after January 31, 2025 through the filing of this report that would have a material impact on the Company’s financial results or require disclosure other than those noted above.

Table of Contents

Item 2.: Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview

The following information should be read in conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this Form 10-Q.

On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows (1) Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter (2) All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive.

Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and security protection products previously acquired by the Company. The Company owns 79.8% of PSSI with 20.2% acquired by several individuals and entities. The Company plans to continue the development of the technology. All sales and marketing activities are through PSSI.

The ~~extent~~Company’s tosecurity ~~which~~products ~~the~~are ~~COVID-19~~licensed ~~pandemic~~from ~~may~~CCS ~~directly~~and ordeveloped ~~indirectly~~by ~~impact~~the ~~our~~company designed ~~business,~~for ~~financial~~personal ~~condition,~~ and ~~results~~collateral ofprotection. ~~operations~~Products isderived ~~highly~~from ~~uncertain~~this ~~and~~technology ~~subject~~are intended to ~~change.~~provide Wepassive ~~considered~~security ~~the~~scanning ~~potential~~units ~~impact~~for ofeither ~~the~~walk-through ~~COVID~~or hand-19held ~~pandemic~~use onto ~~our~~improve ~~estimates~~security ~~and~~for ~~assumptions~~schools and ~~there~~other ~~was~~public facilities. Passive Portal units use electromagnets and do not emit anything (such as x-rays) through the subject. We have also completed a ~~material~~prototype ~~impact~~with tooptional ~~our~~“Digital ~~consolidated~~Imaging,” ~~financial~~which ~~statements~~will asgive the user of ~~and~~the ~~for~~scanner the ~~six~~ability ~~months~~to ~~ended~~recall ~~October~~the ~~31,~~entire ~~2024~~traffic passing through the scanner at any time thereafter.

~~The~~As ~~Company’s~~of ~~security~~May ~~products~~19, ~~are~~2020, ~~licensed from CCS and developed by~~ the ~~company~~Company ~~designed~~added ~~for~~an ~~personal~~IR ~~and~~Camera ~~collateral protection. Products derived from this technology are intended to provide passive security scanning units~~ for ~~either~~detection ~~walk-through~~of orelevated ~~hand-held~~body ~~use~~temperatures ~~to improve security for schools~~ and ~~other~~is ~~public~~presently ~~facilities. Passive~~offering ~~Portal~~these units use electromagnets and do not emit anything (such as x-rays) through the subject. We have also completed a prototype with optional “Digital Imaging,” which will give the user of the scanner the ability to recall the entire traffic passing through the scanner at any time thereafter. products:

As· ofPASSIVE ~~May~~PORTAL ~~19,~~– ~~2020,~~Screens ~~the~~for ~~Company~~Weapons ~~added~~only; an· IRPASSIVE ~~Camera~~PORTAL with EBT – Screens for ~~detection~~Weapons ofand elevated body ~~temperatures~~temperature; ~~and~~· isEBT ~~presently~~Station ~~offering~~– ~~these~~Screens ~~products:~~ for elevated body temperature only.

~~● PASSIVE~~Forward ~~PORTAL~~Looking ~~– Screens~~and ~~for~~Cautionary ~~Weapons only;~~Statements

~~● PASSIVE~~This ~~PORTAL~~report ~~with~~contains ~~EBT – Screens~~forward-looking ~~for~~statements ~~Weapons~~relating to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar terms, variations of such terms or the negative of such terms. These statements are only predictions and ~~elevated~~involve ~~body~~known ~~temperature;~~and unknown risks, uncertainties and other factors. Although forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment, actual results could differ materially from those anticipated in such statements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

~~● EBT~~15 ~~Station – Screens~~Table ~~for~~of ~~elevated body temperature only.~~Contents

~~Forward~~Results ~~Looking~~of ~~and Cautionary Statements~~Operations

~~This~~During ~~report~~the ~~contains~~three ~~forward-looking~~and ~~statements relating to future events or our future financial performance. In some cases, you can identify forward~~nine-~~looking~~months ~~statements~~ending byJanuary ~~terminology such as “may~~31,” ~~“will,”~~2025 ~~“should,”~~the ~~“expect,”~~Company ~~“intend,”~~did ~~“plan,”~~not ~~“anticipate,”~~receive ~~“believe,”~~any ~~“estimate,”~~revenue ~~“predict,”~~compared ~~“potential,”~~to ~~“continue,”~~revenue ~~or similar terms, variations~~ of ~~such~~zero ~~terms~~for or the ~~negative~~three ofmonths ~~such~~period ~~terms. These statements are only predictions~~ and ~~involve known and unknown risks~~$49,012 ~~uncertainties and other factors. Although forward-looking statements, and any assumptions upon which they are based, are made~~ in ~~good~~the ~~faith~~nine ~~and~~months ~~reflect~~period ~~our current judgment, actual results could differ materially from those anticipated~~ in ~~such statements~~2024. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

15Our ~~Table~~operating expenses offor ~~Contents~~the three and nine months ended January 31, 2025 was $316,803 and $851,750 compared to $141,270 and $450,209 for the same periods in 2024. The increase was due primarily to higher nine months consulting costs, which were $93,200 and $429,992 for the three and nine months along with higher general and administrative costs for the three and nine months periods ending January 31, 2025.

~~Results~~Interest and other expenses incurred in the three and nine months periods ended January 31, 2025 was $6,408 and $30,562 compared to interest expense of ~~Operations~~$6,771 and $21,330 for the same periods in 2024. Loss on accounts payable of $250,000 was incurred during the nine months ended January 31, 2025.

~~During~~Change in derivative liability resulted in a change of $5,633 and $13,090 for the three and ~~six-~~nine months ~~ending~~period ~~October~~ended January 31, 2025, compared to a change of $226 and loss of $16,528 for the same period in 2024 We estimate the fair value of the derivative for the conversion feature of our convertible notes payable using the American Binominal Lattice pricing model at the inception of the debt, at the ~~Company~~date ~~did~~of ~~not~~conversions ~~receive~~to ~~any~~equity, ~~revenue~~cash payments and at reporting date, recording a derivative liability, debt discount and a gain or loss on change in derivative liability as applicable. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, and variable conversion prices based on market prices as defined in the respective loan agreements. These inputs are subject to significant changes from period to period; therefore, the estimated fair value of the derivative liability will fluctuate from period to period and the fluctuation may be material.

~~Our~~Total ~~operating expenses~~other income and expense for the three and ~~six~~nine months periods ended January ~~October~~ 31, ~~2024~~2025 was ~~$366,065~~other ~~and~~expense of $~~529~~49,~~582~~391 ~~compared to $143,593~~ and ~~$284,331~~other ~~for~~income ~~the~~of ~~same periods in 2023. The increase was due primarily to higher consulting costs, which were~~ $~~219~~505,~~292~~759 ~~and~~compared ~~$336,792 for the three and six months along with~~to ~~higher~~other ~~general~~income ~~and administrative costs~~ of $~~146~~18,~~773~~455 and ~~$192,790~~other ~~for~~expense ~~the three and six-months periods ending October 31, 2024 compared to general and administrative costs~~ of $5512,~~573~~858 ~~and $75,989~~ for the ~~three-~~same ~~and six-month~~ periods in ~~ended October 31, 2023~~2024.

~~Interest~~Net ~~expenses~~loss ~~incurred~~before innon-controlling interest for the three and ~~six~~nine months ~~periods~~ ended ~~October~~ January 31, ~~2024~~2025 ~~was~~were a net loss of $7267,~~096~~412 and $14345,~~154~~991 compared to ~~interest~~a ~~expense~~net loss of $7122,~~189~~815 and $14438,~~559~~460 for the same periods in ~~2023~~2024. A ~~loan~~After ~~origination~~adjusting ~~fee~~for ofour $5consolidated subsidiary,~~000,~~ net loss onand ~~notes~~net income for the three and nine month periods ended January 31, 2025 were net loss of $5272,~~000~~778 and ~~loss~~$330,124 oncompared ~~accounts~~to ~~payable~~a net loss of $~~250~~121,~~000~~603 ~~was~~and ~~incurred~~$428,389 ~~during~~for the ~~six~~same ~~months~~periods ~~ended~~in ~~October 31,~~ 2024.

~~Change~~Liquidity ~~in derivative liability resulted in a change of $709~~ and ~~$7,457~~Capital ~~for~~Resources the three and six months period ended October 31, 2024, compared to a loss of $28,980 and $16,756 for the same period in 2023 We estimate the fair value of the derivative for the conversion feature of our convertible notes payable using the American Binominal Lattice pricing model at the inception of the debt, at the date of conversions to equity, cash payments and at reporting date, recording a derivative liability, debt discount and a gain or loss on change in derivative liability as applicable. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, and variable conversion prices based on market prices as defined in the respective loan agreements. These inputs are subject to significant changes from period to period; therefore, the estimated fair value of the derivative liability will fluctuate from period to period and the fluctuation may be material.

~~Total~~At ~~other~~January ~~income~~31, 2025 the Company had total current assets of $10,196 and ~~expense~~total ~~for~~current ~~the~~liabilities ~~three~~of $1,489,019 resulting in a working capital deficit of $1,478,823. Included in our current liabilities and ~~six~~working ~~months~~capital ~~periods~~deficit ~~ended~~at ~~October~~January 31, ~~2024~~2025 ~~was~~are ~~other~~derivative ~~income~~liabilities of $~~760~~24,~~260~~121 related ~~and~~ to the conversion features of certain of our convertible notes payable, convertible notes of $~~456~~185,~~368~~762, ~~compared~~net ~~to other~~of discount, payables due related parties of $557,407, accounts payable, accrued expense of $3680,~~169~~028 and notes payables of $31382,~~315~~905. ~~for~~We ~~the~~anticipate ~~same~~that ~~periods~~ in ~~2023~~the short term, operating funds will continue to be provided by related parties and other lenders.

~~Net~~During ~~loss before non-controlling interest for~~ the ~~three~~nine ~~and~~months ~~six month periods~~ ended ~~October~~January 31, ~~2024~~2025, ~~were a~~ net ~~income~~cash ~~of $394,195~~used ~~and~~in ~~net~~operating ~~loss~~activities ofwas $73167,~~214~~146 compared ~~net~~to ~~loss~~cash used of $~~179~~5,~~762~~338 ~~and~~in ~~$315,646 for~~ the same ~~periods~~period in ~~2023~~2024. ~~After~~Net ~~adjusting~~cash ~~for~~used ~~our~~in ~~consolidated subsidiary, net loss and net income for~~ the ~~three~~nine ~~and six~~ month ~~periods~~period ~~ended~~in ~~October~~2025 ~~31,~~consisted ~~2024~~of ~~were~~ net ~~income~~loss of $~~398~~345,~~527~~991, ~~and~~payables ~~net~~to ~~loss~~related parties of $62390,~~712~~629, ~~compared~~accounts topayable ~~a net loss~~ of $~~179~~506,~~117~~860 and ~~$307,236~~debt ~~for~~extinguishment ~~the~~of ~~same periods in 2023~~$773,231.

~~Liquidity~~16 ~~and~~Table ~~Capital~~of ~~Resources~~ Contents

AtDuring ~~October 31, 2024~~ the ~~Company~~nine ~~had~~months ~~total~~ended ~~current~~January ~~assets~~31, ~~of $7~~2025,~~827~~ ~~and~~net ~~total~~cash ~~current~~provided ~~liabilities~~by offinancing activities was $1169,~~342,206~~572 ~~resulting~~consisting inof a ~~working~~note ~~capital~~payable ~~deficit~~net of $1178,~~334,379.~~000 ~~Included in our current liabilities~~ and ~~working~~note ~~capital~~to ~~deficit at October 31, 2024 are derivative liabilities totaling $29,754~~ related toparty ~~the conversion features~~ of ~~certain of our convertible notes payable~~$6,975 ~~convertible~~offset ~~notes~~by repayment of $~~279~~15,~~085,~~403. We ~~net~~have ofhad ~~discount,~~no ~~payables~~revenue ~~due~~and ~~related~~paid ~~parties~~expenses ~~of $526,958, accounts payable~~ and ~~accrued~~costs ~~expense~~with ofproceeds ~~$57,349~~from ~~and~~the ~~notes~~issuance ~~payables~~ of ~~$220,722.~~securities Weas ~~anticipate~~well ~~that~~as inby ~~the~~loans ~~short~~from ~~term~~investor, ~~operating~~stockholders ~~funds~~and ~~will~~other ~~continue to be provided by~~ related parties ~~and other lenders~~.

~~During~~Our ~~the~~immediate ~~six~~goal ~~months~~is ~~ended October 31, 2024, net cash used in operating activities was $40,603 compared~~ to ~~cash~~provide ~~used~~funding offor ~~$23,902 in~~ the ~~same~~completion ~~period~~of ~~in 2023. Net cash used in~~ the production ~~six~~of ~~month~~Offender ~~period~~Alert inPassive ~~2024~~Scan ~~consisted~~licensed offrom ~~net~~CCS. ~~loss~~The ofOffender ~~$73,214,~~Alert ~~change~~Passive inScan ~~payables~~is toan ~~related~~advanced ~~parties~~passive ofscanning ~~$65,180,~~system ~~increase~~for indetecting ~~accounts payable of $382,953~~ and ~~gain~~identifying onconcealed ~~debt extinguishment of $428,065~~threats.

~~During~~We ~~the~~believe ~~six~~a ~~months~~related ~~ended~~party ~~October~~and ~~31,~~other ~~2024,~~lenders ~~net~~will ~~cash~~provide ~~provided~~sufficient byfunds ~~financing~~to ~~activities~~carry ~~was~~on ~~$40,660~~general ~~consisting~~operations ofin athe ~~note~~near ~~payable~~term ~~net~~and offund ~~$40,000~~DTC’s production and ~~note~~sales. We expect to ~~related~~raise ~~party~~additional ~~net~~funds offrom ~~repayment~~the sale of ~~$660. We~~securities, ~~have~~stockholder ~~had~~loans ~~no revenue~~ and ~~paid~~convertible ~~expenses~~debt. However, ~~and~~we ~~costs~~may ~~with~~not ~~proceeds~~be ~~from~~successful ~~the~~in ~~issuance~~our ofefforts ~~securities~~to asobtain ~~well~~financing asto bycarry ~~loans~~out ~~from~~our ~~investor,~~business ~~stockholders and other related parties~~plan.

16See ~~Table~~the notes to our condensed consolidated financial statements for a discussion of ~~Contents~~recently issued accounting pronouncements that we have either implemented or that may have a material future impact on our financial position or results of operations.

~~Our~~Off-Balance ~~immediate~~Sheet goal is to provide funding for the completion of the production of Offender Alert Passive Scan licensed from CCS. The Offender Alert Passive Scan is an advanced passive scanning system for detecting and identifying concealed threats.Arrangements

We ~~believe~~have ano ~~related~~off-balance ~~party~~sheet ~~and~~arrangements ~~other~~that ~~lenders~~have ~~will~~or ~~provide~~are ~~sufficient~~reasonably ~~funds~~likely to ~~carry~~have ona ~~general~~current ~~operations~~or infuture ~~the~~effect ~~near~~on ~~term~~our ~~and~~financial ~~fund~~condition, ~~DTC’s~~changes ~~production~~in ~~and~~financial ~~sales. We~~condition, ~~expect~~revenues toor ~~raise~~expenses, ~~additional~~results ~~funds from the sale~~ of ~~securities~~operations, ~~stockholder loans and convertible debt. However~~liquidity, wecapital ~~may~~expenditures ~~not~~or becapital ~~successful~~resources inthat ~~our~~is ~~efforts~~material to ~~obtain financing to carry out our business plan~~stockholders.

See the notes to our condensed consolidated financial statements for a discussion of recently issued accounting pronouncements that we have either implemented or that may have a material future impact on our financial position or results of operations.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

This item is not required for a smaller reporting company.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures. As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our management including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) (“Exchange Act”). Based on this evaluation, the principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in applicable rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, in a manner that allows timely decisions regarding required disclosures.

We operate with a limited number of accounting and financial personnel. Although we retain the services of an experienced certified public accountant, we have been unable to implement proper segregation of duties over certain accounting and financial reporting processes, including timely and proper documentation of material transactions and agreements. We believe these control deficiencies represent material weaknesses in internal control over financial reporting.

Despite the material weaknesses in financial reporting noted above, we believe that our consolidated financial statements included in this report fairly present our financial position, results of operations and cash flows as of and for the periods presented in all material respects.

Changes in Internal Control over Financial Reporting. There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

There are no material pending legal proceedings to which we are a party or to which any of our property is subject and, to the best of our knowledge, no such actions against us are contemplated or threatened.

Item 1A. Risk Factors

This item is not required for a smaller reporting company.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued ~~100~~850,000 shares of common stock with a value of $1055,000 for the payment of consulting fees.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued ~~431~~1,~~181~~631,143 shares of common stock for the conversion of 726 shares of series D preferred shares.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 10,000,000 shares with an aggregate value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued ~~191~~1,~~314~~ 250,000 shares of ~~series~~common ~~B preferred shares~~stock ~~to settle $789,332 for accrued payables. The result of this issuance was a gain on debt of approximately $723,065.~~with

~~During~~Preferred ~~the six months ending October 31, 2024 the Company issued 79,991 shares of series B for settling $329,930 of accrued payables due to related parties.~~ Stock

During the nine months ending January 31, 2025 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares.

During the nine months ending January 31, 2025 the Company issued 213,314 shares of series B preferred shares to settle $843,831 for accrued payables. The result of this issuance was a gain on debt of approximately $773,231.

During the nine months ending January 31, 2025 the Company issued 94,991 shares of series B preferred with a value of $367,431 to 2 related parties for accrued liabilities.

Item 3. Defaults Upon Senior Securities

This item is not applicable.

Item 4. Mine Safety Disclosure

This item is not applicable.

Item 5. Other Information

Not applicable

Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of this report:

Exhibit No.		Description of Exhibit
31.1		Section 302 Certification of Chief Executive Officer and Chief Financial Officer
32.1		Section 1350 Certification of Chief Executive Officer and Chief Financial Officer
101 INS*		Inline XBRL Instance Document ~~(the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)~~
101SCH*		Inline XBRL Taxonomy Extension Schema
101 CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase
101 DEF*		Inline XBRL Taxonomy Extension Definition Linkbase
101 LAB*		Inline XBRL Taxonomy Extension Label Linkbase
101 PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Exchange Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DEFENSE TECHNOLOGIES INTERNATIONAL CORP.
Date: December 23, 2024	By:	/s/ MERRILL W. MOSES
Date: March 31, 2025	By:	/s/ Merrill W. Moses
		Merrill W. MosesChief Executive Officer
		Merrill W. Moses
		Chief Executive Officer
		Acting Chief Financial Officer

Filing Compare · DEFENSE TECHNOLOGIES INTERNATIONAL CORP.